Visual impairment due to age‐related macular degeneration during 40 years in Finland and the impact of novel therapies

PURPOSE: To evaluate the changes in visual impairment (VI) due to age‐related macular degeneration (AMD) during the past 40 years and the impact of novel therapies at population level. METHODS: In this nationwide register‐based study, we assessed the incidence, prevalence, severity, and onset age of...

Descripción completa

Detalles Bibliográficos
Autores principales: Purola, Petri, Kaarniranta, Kai, Ojamo, Matti, Gissler, Mika, Uusitalo, Hannu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087211/
https://www.ncbi.nlm.nih.gov/pubmed/35912685
http://dx.doi.org/10.1111/aos.15224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087211/
https://www.ncbi.nlm.nih.gov/pubmed/35912685
http://dx.doi.org/10.1111/aos.15224

Ejemplares similares